Daily Edition · Page 1

THE DAILY INDEX

Technology, AI, software, security, crypto and business

Across today’s newsletters

Today’s Index

GOOGLE REVEALS NANO BANANA 2 AI IMAGE MODEL, COMING TO GEMINI TODAY

Nano Banana 2, also known as Gemini 3.1 Flash Image, delivers results similar to Nano Banana Pro but with the speed of the non-pro Flash variant. The new image generator has more advanced world knowledge, which gives it the necessary information to render objects with greater fidelity and create more accurate infographics. Nano Banana 2 will replace both the standard and Pro variants of Nano Banana across the Gemini app, Search, AI Studio, Vertex AI, and Flow. Example images generated with the model are available in the article.

WE BUILT A VIDEO RENDERING ENGINE BY LYING TO THE BROWSER ABOUT WHAT TIME IT IS

Replit developed a unique video rendering engine to turn any web page into a deterministic video file, overcoming the challenge that browsers are real-time systems ill-suited for frame-perfect capture. Its solution involves injecting a JavaScript virtual clock into the browser, which replaces native timing APIs like `setTimeout` and `requestAnimationFrame`, so time advances only when commanded. This system also has a complex pipeline for handling video elements by preprocessing them server-side and rendering frames to a canvas.

MALICIOUS NEXT.JS REPOS TARGET DEVELOPERS VIA FAKE JOB INTERVIEWS

Microsoft discovered Trojanized Next.js repositories linked to North Korea's Lazarus APT that deliver backdoors through fake job-recruitment coding challenges, achieving RCE and persistent C2 access on developer machines. The repositories exploit VS Code workspace automation via malicious .vscode/tasks.json files or embed obfuscated loaders in build assets that fetch attacker-controlled JavaScript at runtime. Security teams should enforce strict IDE trust policies, monitor for anomalous Node.js outbound connections, and treat developer workflows as a privileged attack surface.

A NEW BIPARTISAN BILL WANTS TO ENSURE THE NEXT CENTURY OF TECH IS WRITTEN IN AMERICA

The Promoting Innovation in Blockchain Development Act of 2026 would protect good-faith open-source software developers from Section 1960 criminal statutes designed for money laundering, addressing the legal gray zone that has chilled American blockchain development competitiveness. Solana's ecosystem grew 84% year-over-year in new developers in 2024, illustrating how clear regulatory environments attract talent building digital financial infrastructure for payments, DeFi, and identity applications. America must follow its historical pattern, where regulation followed innovation rather than preceding it. The upcoming SEC engagement-focused shift under Paul Atkins and CLARITY Act progress is critical to ensuring talent, standards, and capital for internet capital markets consolidate domestically rather than migrating to clearer foreign jurisdictions.

NETFLIX DITCHES DEAL FOR WARNER BROS. DISCOVERY AFTER PARAMOUNT'S OFFER IS DEEMED SUPERIOR

Netflix is walking away from a deal to buy Warner Bros. Discovery's (WBD) studio and streaming assets as its board deemed on Thursday that a revised bid by Paramount is a superior offer. Paramount raised its bid earlier this week to $31 per share in cash. Netflix had granted WBD a seven-day waiver to re-engage with Paramount last week. Paramount's offer is for the entirety of the company.

OPENAI'S KEVIN WEIL ON THE FUTURE OF SCIENTIFIC DISCOVERY

OpenAI's VP of Science, Kevin Weil, recently had an interview where he discussed how AI capabilities are progressing to the future of robotic labs, how founders should think about building with AI, and why this might be the best moment in history to start a company. This post contains highlights of the interview along with a link to a video of the chat. Weil is now focused on accelerating scientific discovery with AI. His previous experience includes leading product teams at Twitter, Facebook, and Instagram.

TOMORROW'S SMART PILLS WILL DELIVER DRUGS AND TAKE BIOPSIES

Doctors may soon prescribe pills that can travel through the digestive system and check for tissue health. Diagnosis for gastrointestinal diseases is often complicated, and treatment can bring serious side effects. Capsules are able to handle much of that work and could even release drugs exactly where they're needed or snip biopsy samples for analysis. The technology could transform care and make screening for disease less invasive and more accessible.

TLDR IndexPage 1